Xtl Biopharmaceuticals (XTLB) EBITDA (2009 - 2016)
Xtl Biopharmaceuticals (XTLB) reported EBITDA of -$576,000 for the year ended Dec 31, 2024, compared with -$738,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) EBITDA (2009 - 2016) Analysis & Trends
Dating back to the year ended Dec 31, 2009, Xtl Biopharmaceuticals' EBITDA record includes 14 years.
- The figure for the year ended Dec 31, 2024 ranks as the highest annual EBITDA since the year ended Dec 31, 2013.
- According to Business Quant data, EBITDA came in at -$738,000 in the year ended Dec 31, 2023, -$879,000 in the year ended Dec 31, 2022, -$1.03 million in the year ended Dec 31, 2021 and -$947,000 in the year ended Dec 31, 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Xtl Biopharmaceuticals | 2.11 Bn | 2.11 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2016 | -465,000.00 |
| Dec 31, 2015 | -2.36 Mn |
| Sep 30, 2015 | -395,000.00 |
| Jun 30, 2015 | -479,000.00 |
| Dec 31, 2014 | -648,000.00 |
| Sep 30, 2014 | -356,000.00 |
| Jun 30, 2014 | -392,000.00 |
| Mar 31, 2014 | -574,000.00 |
| Dec 31, 2013 | 821,000.00 |
| Sep 30, 2013 | 906,000.00 |
| Jun 30, 2013 | -921,000.00 |
| Mar 31, 2013 | -845,000.00 |
| Dec 31, 2010 | -282,000.00 |
| Sep 30, 2010 | -287,000.00 |
| Jun 30, 2010 | -315,000.00 |
| Mar 31, 2010 | -333,000.00 |
| Dec 31, 2009 | -305,000.00 |
| Sep 30, 2009 | 16,000.00 |
| Jun 30, 2009 | 1.22 Mn |
| Mar 31, 2009 | 1.65 Mn |
API Access
Xtl Biopharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();